BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7114312)

  • 1. Corneal and lenticular opacities in mentally retarded young adults treated with thioridazine and chlorpromazine.
    Gualtieri CT; Lefler WH; Guimond M; Staye JI
    Am J Psychiatry; 1982 Sep; 139(9):1178-80. PubMed ID: 7114312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of thioridazine and withdrawal dyskinesias on workshop performance of mentally retarded young adults.
    Breuning SE; Davis VJ; Matson JL; Ferguson DG
    Am J Psychiatry; 1982 Nov; 139(11):1447-54. PubMed ID: 6753612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total dosage of chlorpromazine and ocular opacities.
    Buffaloe WJ; Johnson AW; Sandifer MG
    Am J Psychiatry; 1967 Aug; 124(2):250-1. PubMed ID: 4951587
    [No Abstract]   [Full Text] [Related]  

  • 4. Observations on the acoustic reflex threshold in institutionalized retarded adults taking mellaril and/or thorazine.
    Niswander PS; Helfner-Mitchell F
    Ear Hear; 1988 Feb; 9(1):9-14. PubMed ID: 3342946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deposits in the lens and cornea of the eye during long-term chlorpromazine medication.
    Rasmussen K; Kirk L; Faurbye A
    Acta Psychiatr Scand; 1976 Jan; 53(1):1-6. PubMed ID: 1251751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of single-double blind procedures, maintenance of placebo effects and drug induced dyskinesia with mentally retarded persons.
    Breuning SE; Ferguson DG; Cullari S
    Appl Res Ment Retard; 1980; 1(3-4):175-92. PubMed ID: 7337456
    [No Abstract]   [Full Text] [Related]  

  • 7. Opacities and thioridazine.
    Westlin WF
    Am J Psychiatry; 1983 May; 140(5):658-9. PubMed ID: 6846614
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of prolonged phenothiazine intake on psychotic and other hospitalized children.
    McAndrew JB; Case Q; Treffert DA
    J Autism Child Schizophr; 1972; 2(1):75-91. PubMed ID: 5067403
    [No Abstract]   [Full Text] [Related]  

  • 9. Ocular changes produced by chlorpromazine.
    Dencker SJ; Enoksson P
    Acta Ophthalmol (Copenh); 1966; 44(3):397-403. PubMed ID: 5953234
    [No Abstract]   [Full Text] [Related]  

  • 10. Ocular changes associated with chlorpromazine therapy. A preliminary report.
    Edler K
    Acta Ophthalmol (Copenh); 1966; 44(3):405-9. PubMed ID: 5953235
    [No Abstract]   [Full Text] [Related]  

  • 11. [Complications on the part of the eyes during employment of psychotropic drugs (review of the foreign literature)].
    Gol'dovskaia IL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(6):935-9. PubMed ID: 4905472
    [No Abstract]   [Full Text] [Related]  

  • 12. Asymmetric anterior segment changes induced by chlorpromazine.
    Deluise VP; Flynn JT
    Ann Ophthalmol; 1981 Aug; 13(8):953-5. PubMed ID: 7294636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorpromazine-induced skin pigmentation with corneal and lens opacities.
    Huff LS; Prado R; Pederson JF; Dunnick CA; Lucas LM
    Cutis; 2014 May; 93(5):247-50. PubMed ID: 24897137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical evaluation of mesoridazine in mentally retarded patients.
    Zaleski W
    Can Psychiatr Assoc J; 1970 Jun; 15(3):319-22. PubMed ID: 4913609
    [No Abstract]   [Full Text] [Related]  

  • 15. Eye findings in patients with phenylketonuria.
    Zwaan J
    Arch Ophthalmol; 1983 Aug; 101(8):1236-7. PubMed ID: 6882253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxic effects of phenothiazines on the eye.
    Boet DJ
    Doc Ophthalmol; 1970 Jul; 28(1):1-69. PubMed ID: 5312274
    [No Abstract]   [Full Text] [Related]  

  • 17. Ocular (pigmentary) effects of psychotropic drugs.
    Appleton WS; Shader RI; DiMascio A
    Conn Med; 1970 Jan; 34(1):25-8. PubMed ID: 4903792
    [No Abstract]   [Full Text] [Related]  

  • 18. Kerato-lenticular ocular deposits and visual impairment with prolonged chlorpromazine use: A case series.
    Gowda GS; Hegde A; Shanbhag V; Narayanaswamy JC; Jaisoorya TS
    Asian J Psychiatr; 2017 Feb; 25():188-190. PubMed ID: 28262147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of the ocular side effects of chlorpromazine in the Tuscaloosa Veterans Administration patient population.
    Alexander LJ; Bowerman L; Thompson LR
    J Am Optom Assoc; 1985 Nov; 56(11):872-6. PubMed ID: 4078212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tardive dyskinesia as a possible sequel of long-term therapy with phenothiazines.
    Paulson GW; Rizvi CA; Crane GE
    Clin Pediatr (Phila); 1975 Oct; 14(10):953-5. PubMed ID: 1100296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.